|
RNF26 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.90170101888043E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.35129701767301E-11 |
| Normal-vs-Stage2 |
6.987200E-04 |
| Normal-vs-Stage3 |
2.51798581984986E-13 |
| Normal-vs-Stage4 |
1.38310000119546E-08 |
| Stage1-vs-Stage2 |
6.272000E-02 |
| Stage1-vs-Stage3 |
3.141600E-02 |
| Stage1-vs-Stage4 |
1.207000E-01 |
| Stage2-vs-Stage3 |
1.300780E-03 |
| Stage2-vs-Stage4 |
1.354390E-02 |
| Stage3-vs-Stage4 |
9.915600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.11053396981242E-13 |
| Normal-vs-AfricanAmerican |
2.344400E-03 |
| Normal-vs-Asian |
6.79860000518673E-08 |
| Caucasian-vs-AfricanAmerican |
1.997390E-01 |
| Caucasian-vs-Asian |
3.953800E-01 |
| AfricanAmerican-vs-Asian |
5.188000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.80930001483881E-09 |
| Normal-vs-Female |
1.89781523829424E-12 |
| Male-vs-Female |
8.157800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.36810007766996E-10 |
| Normal-vs-Age(41-60Yrs) |
4.46559456079854E-11 |
| Normal-vs-Age(61-80Yrs) |
1.37869999861095E-08 |
| Normal-vs-Age(81-100Yrs) |
7.837800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.144200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.382200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.916000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.711000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.774000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.232800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.250500E-02 |
| Classical-VS-Follicular |
4.258300E-02 |
| Classical-VS-Other |
4.299200E-01 |
| Classical-VS-Normal |
1.66977542903624E-12 |
| Tall-VS-Follicular |
1.601010E-03 |
| Tall-VS-Other |
9.296200E-01 |
| Tall-VS-Normal |
1.58900004265661E-10 |
| Follicular-VS-Other |
2.355200E-01 |
| Follicular-VS-Normal |
1.999470E-04 |
| Other-VS-Normal |
2.016000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.34279999844489E-08 |
| Normal-vs-N1 |
3.30846461338297E-14 |
| N0-vs-N1 |
1.87897999999187E-05 |
|
|
